Cargando…
Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen of coronavirus disease 2019 (COVID-19), has infected hundreds of millions of people and caused millions of deaths. Looking for valid druggable targets with minimal side effects for the treatment of COVID-19 remains critical....
Autores principales: | Wang, Jianhua, Liu, Jiaojiao, Luo, Menghan, Cui, Hui, Zhang, Wenwen, Zhao, Ke, Dai, Hongji, Song, Fangfang, Chen, Kexin, Yu, Ying, Zhou, Dongming, Li, Mulin Jun, Yang, Hongxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556799/ https://www.ncbi.nlm.nih.gov/pubmed/36267550 http://dx.doi.org/10.1016/j.isci.2022.105348 |
Ejemplares similares
-
3DCoop: An approach for computational inference of cell-type-specific transcriptional regulators cooperation in 3D chromatin
por: Yi, Xianfu, et al.
Publicado: (2022) -
Network-Based Inference Methods for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015) -
Pathway-based drug repositioning using causal inference
por: Li, Jiao, et al.
Publicado: (2013) -
Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
por: Liang, Rui, et al.
Publicado: (2020) -
Recycling side-effects into clinical markers for drug repositioning
por: Duran-Frigola, Miquel, et al.
Publicado: (2012)